The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study
Open accessAbstract
OBJECTIVE: To estimate the potential cost effectiveness of a population-wide risk factor reduction programme aimed at preventing cardiovascular disease. DESIGN: Economic modelling analysis. SETTING: England and Wales. Population Entire population. Model Spreadsheet model to quantify the reduction in cardiovascular disease over a decade, assuming the benefits apply consistently for men and women across age and risk groups. MAIN OUTCOME MEASURES: Cardiovascular events avoided, quality adjusted life years gained, and savings in healthcare costs for a given effectiveness; estimates of how much it would be worth spending to achieve a specific outcome. RESULTS: A programme across the entire population of England and Wales (about 50 million people) that reduced cardiovascular events by just 1% would result in savings to the health service worth at least £30m (€34m; $48m) a year compared with no additional intervention. Reducing mean cholesterol concentrations or blood pressure levels in the population by 5% (as already achieved by similar interventions in some other countries) would result in annual savings worth at least £80m to £100m. Legislation or other measures to reduce dietary salt intake by 3 g/day (current mean intake approximately 8.5 g/day) would prevent approximately 30,000 cardiovascular events, with savings worth at least £40m a year. Legislation to reduce intake of industrial trans fatty acid by approximately 0.5% of total energy content might gain around 570,000 life years and generate NHS savings worth at least £230m a year. CONCLUSIONS: Any intervention that achieved even a modest population-wide reduction in any major cardiovascular risk factor would produce a net cost saving to the NHS, as well as improving health. Given the conservative assumptions used in this model, the true benefits would probably be greater.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Self-citationAn updated coronary risk profile. A statement for health professionals.
Anderson, K. M., Wilson, P. W., Odell, P. M., & Kannel, W. B. (1991) · Circulation · doi:10.1161/01.cir.83.1.356 · Cited by 1,834
Projected effect of dietary salt reductions on future cardiovascular disease
Bibbins-Domingo, K., Chertow, G. M., Coxson, P. G., Moran, A., Lightwood, J. M., Pletcher, M. J., & Goldman, L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907355 · Cited by 1,253
He, F. J., & MacGregor, G. A. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2008.144 · Cited by 1,123
Health effects of trans-fatty acids: experimental and observational evidence
Mozaffarian, D., Aro, A., & Willett, W. C. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602973 · Cited by 662
Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002
Björck, L., Rosengren, A., Bennett, K., Lappas, G., & Capewell, S. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn554 · Cited by 264
Self-citationAspelund, T., Gudnason, V., Magnusdottir, B. T., Andersen, K., Sigurdsson, G., Thorsson, B., Steingrimsdottir, L., Critchley, J., Bennett, K., O'Flaherty, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013957 · Cited by 106 · cited 1×
“Furthermore, much larger reductions in entire populations have been documented since the 1980s. For instance, cholesterol reductions of 22% in Finland, 14% in Iceland, 10% in Sweden, and 6% in the United States have been reported.”
BackgroundSelf-citation
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Olsen, M. H., Angell, S. Y., Asma, S., Boutouyrie, P., Burger, D., Chirinos, J. A., Damasceno, A., Delles, C., Gimenez-Roqueplo, A.-P., Hering, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31134-5 · Cited by 939
Salt reduction in the United Kingdom: a successful experiment in public health
He, F. J., Brinsden, H. C., & MacGregor, G. A. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2013.105 · Cited by 456
Baber, U., Mehran, R., Sartori, S., Schoos, M. M., Sillesen, H., Muntendam, P., Garcia, M. J., Gregson, J., Pocock, S., Falk, E., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.017 · Cited by 461
Dietary advice for reducing cardiovascular risk
Brunner, E., Thorogood, M., Rees, K., & Hewitt, G. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002128.pub2 · Cited by 351
Huffman, M. D., Capewell, S., Ning, H., Shay, C. M., Ford, E. S., & Lloyd-Jones, D. M. (2012) · Circulation · doi:10.1161/circulationaha.111.070722 · Cited by 299
Self-citationSodium intake and its reduction by food reformulation in the European Union — A review
Kloss, L., Meyer, J. D., Graeve, L., & Vetter, W. (2015) · NFS Journal · doi:10.1016/j.nfs.2015.03.001 · Cited by 279
Lee, J. T., Hamid, F., Pati, S., Atun, R., & Millett, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127199 · Cited by 278
Systematic review of dietary salt reduction policies: Evidence for an effectiveness hierarchy?
Hyseni, L., Elliot-Green, A., Lloyd-Williams, F., Kypridemos, C., O’Flaherty, M., McGill, R., Orton, L., Bromley, H., Cappuccio, F. P., & Capewell, S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177535 · Cited by 278
Self-citationO'Flaherty, M., Buchan, I., & Capewell, S. (2013) · Heart · doi:10.1136/heartjnl-2012-302300 · Cited by 165
Self-citationCollins, M., Mason, H., O’Flaherty, M., Guzman-Castillo, M., Critchley, J., & Capewell, S. (2014) · Value in Health · doi:10.1016/j.jval.2014.03.1722 · Cited by 104
Self-citationWhich interventions offer best value for money in primary prevention of cardiovascular disease
Cobiac, L. J., Magnus, A., Lim, S., Barendregt, J. J., Carter, R., & Vos, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041842 · Cited by 97
United Nations' dietary policies to prevent cardiovascular disease
Mozaffarian, D., & Capewell, S. (2011) · BMJ · doi:10.1136/bmj.d5747 · Cited by 67
Self-citationKhan, S. U., Talluri, S., Riaz, H., Rahman, H., Nasir, F., Bin Riaz, I., Sattur, S., Ahmed, H., Kaluski, E., & Krasuski, R. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318766612 · Cited by 61
McNaughton, R. J., & Shucksmith, J. (2015) · Journal of Public Health · doi:10.1093/pubmed/fdu066 · Cited by 30
Stevanović, J., O’Prinsen, A. C., Verheggen, B. G., Schuiling-Veninga, N., Postma, M. J., & Pechlivanoglou, P. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.01.008 · Cited by 12
Metadata
- Authors
- Barton, P., Andronis, L., Briggs, A., McPherson, K., & Capewell, S.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2011-07-28
- Volume
- 343
- Issue
- jul28 1
- Pages
- d4044-d4044
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2029030193
- Cited by
- 195
- References
- 8
- FWCI
- 17.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.